I agree that this site is using cookies. You can find further informations here.
X
Lagnf, Abdalhamid M
~ 100  results:
Search for persons X
?
1

Eravacycline, the first four years: health outcomes and tol..:

Kunz Coyne, Ashlan J. ; Alosaimy, Sara ; Lucas, Kristen...
Microbiology Spectrum.  12 (2024)  1 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
2

Risk Factors for Carbapenem-ResistantEnterobacteralesClinic..:

Rebold, Nicholas ; Lagnf, Abdalhamid M. ; Alosaimy, Sara...
Microbiology Spectrum.  11 (2023)  1 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
3

Clinical Characteristics Associated with Bacterial Bloodstr..:

Rebold, Nicholas ; Alosaimy, Sara ; Morrisette, Taylor...
Infectious Diseases and Therapy.  11 (2022)  3 - p. 1281-1296 , 2022
Link: https://doi.org/10.1007/..
 
?
4

633. Eravacycline Use in Immunocompromised Patients: Multic..:

Kunz Coyne, Ashlan J ; Allosaimy, Sara ; Molina, Kyle C...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
5

Real-World, Multicenter Case Series of Patients Treated wit..:

Morrisette, Taylor ; Alosaimy, Sara ; Lagnf, Abdalhamid M....
Infectious Diseases and Therapy.  , 2022
Link: https://doi.org/10.1007/..
 
?
6

1422. A Multi-Center Evaluation of Omadacycline for Multi-D..:

Ghali, Amer El ; Ghali, Amer El ; Allosaimy, Sara...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
7

679. Traditional vs. Alternative Agents in Patients with Lo..:

Holger, Dana J ; Lagnf, Abdalhamid M ; Belza, Ana Christine...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
8

Clinical Outcomes of Eravacycline in Patients Treated Predo..:

Alosaimy, Sara ; Morrisette, Taylor ; Lagnf, Abdalhamid M....
Microbiology Spectrum.  10 (2022)  5 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
9

Nephrotoxicity of Vancomycin in Combination With Beta-Lacta..:

Alosaimy, Sara ; Lagnf, Abdalhamid M ; Hobbs, Athena L V...
Clinical Infectious Diseases.  76 (2022)  3 - p. e1444-e1455 , 2022
Link: https://doi.org/10.1093/..
 
?
10

Multicenter Cohort Study of Ceftaroline Versus Daptomycin f..:

Zasowski, Evan J ; Trinh, Trang D ; Claeys, Kimberly C...
Open Forum Infectious Diseases.  9 (2021)  3 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
11

Early Multicenter Experience With Imipenem-Cilastatin-Releb..:

Rebold, Nicholas ; Morrisette, Taylor ; Lagnf, Abdalhamid M...
Open Forum Infectious Diseases.  8 (2021)  12 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
12

1288. Evaluation of Predictors for Clinical Success in Pati..:

Alosaimy, Sara ; Morrisette, Taylor ; Lagnf, Abdalhamid M...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S733-S733 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Preliminary, Real-world, Multicenter Experience With Omadac..:

Morrisette, Taylor ; Alosaimy, Sara ; Philley, Julie V...
Open Forum Infectious Diseases.  8 (2021)  2 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
14

Real-world, Multicenter Experience With Meropenem-Vaborbact..:

Alosaimy, Sara ; Lagnf, Abdalhamid M ; Morrisette, Taylor...
Open Forum Infectious Diseases.  8 (2021)  8 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
15

Standardized Treatment and Assessment Pathway Improves Mort..:

Alosaimy, Sara ; Lagnf, Abdalhamid M ; Morrisette, Taylor...
Open Forum Infectious Diseases.  8 (2021)  7 - p. , 2021
Link: https://doi.org/10.1093/..
 
1-15